Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Rajan Sharma is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/06/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
05/29/2025 | DBVT | Buy Now | DBV Technologies | $8.55 | -15.2% | Rajan Sharma35% | → $7.25 | Reinstates | → Sell | Get Alert |
05/30/2024 | AZN | Buy Now | AstraZeneca | $72.99 | 32.89% | Rajan Sharma35% | → $97 | Initiates | → Buy | Get Alert |
05/30/2024 | GSK | Buy Now | GSK | $41.23 | 14.01% | Rajan Sharma35% | → $47 | Initiates | → Neutral | Get Alert |
11/22/2023 | MOR | Buy Now | MorphoSys | — | — | Rajan Sharma35% | $9.25 → $4.75 | Maintains | Neutral | Get Alert |
09/15/2023 | MOR | Buy Now | MorphoSys | — | — | Rajan Sharma35% | $3.5 → $9.25 | Upgrade | Sell → Neutral | Get Alert |
06/20/2023 | IMCR | Buy Now | Immunocore Hldgs | $37.94 | 108.25% | Rajan Sharma35% | → $79 | Reiterates | → Overweight | Get Alert |
12/16/2022 | IMCR | Buy Now | Immunocore Hldgs | $37.94 | — | Rajan Sharma35% | — | Upgrade | Neutral → Buy | Get Alert |